Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate Therapy
- 1 April 2003
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 18 (4), 610-614
- https://doi.org/10.1359/jbmr.2003.18.4.610
Abstract
Cyclical intravenous therapy with pamidronate improves the clinical course in children and adolescents with osteogenesis imperfecta (OI). In this study, we evaluated the effect of this therapy on lumbar spine bone mass (bone mineral content [BMC]), size (bone volume [BV]), and density (volumetric bone mineral density [vBMD]). Results from 56 patients (age, 0.2-15.9 years; 25 girls) on long-term pamidronate treatment were compared with those of 167 patients who had not received pamidronate before densitometry. In all patients who received pamidronate, BMC, BV, and vBMD increased above levels expected for untreated patients (p < 0.001 in each case). After 4 years of treatment, BMC, BV, and vBMD were 154%, 44%, and 65% higher, respectively, in treated than in untreated patients who were matched for age and OI type. A multiple regression model showed that baseline BMC was negatively associated with the increase in BMC. In conclusion, the bone mass increase in pediatric OI patients receiving pamidronate is caused by increases in both bone size and density. Patients with larger deficits in bone mass at baseline have a more marked bone mass gain during therapy.Keywords
This publication has 17 references indexed in Scilit:
- The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfectaJCI Insight, 2002
- Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfectaArchives of Disease in Childhood, 2002
- Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization DefectJournal of Bone and Mineral Research, 2002
- Changes in Bone Density During Childhood and Adolescence: An Approach Based on Bone's Biological OrganizationJournal of Bone and Mineral Research, 2001
- Type V Osteogenesis Imperfecta: A New Form of Brittle Bone DiseaseJournal of Bone and Mineral Research, 2000
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaNew England Journal of Medicine, 1998
- Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptidesBone, 1994
- Lumbar bone mineral content measured by dual energy X‐ray absorptiometry in newborns and infantsActa Paediatrica, 1992
- New approaches for interpreting projected bone densitometry dataJournal of Bone and Mineral Research, 1992
- Measurement of Bone Mineral Content of the Lumbar Spine by Dual Energy X-Ray Absorptiometry in Normal Children: Correlations with Growth ParametersJournal of Clinical Endocrinology & Metabolism, 1990